456. Deputy Billy Kelleher asked the Minister for Health the status of the drug Translarna for the treatment of Duchenne muscular dystrophy, which is currently available to 80% of eligible persons across the EU, including in Northern Ireland, Scotland, England, Wales and the Isle of Man; the details of the engagement between the HSE and the manufacturer to date; and if he will make a statement on the matter. [11194/17]

Summary

456. Deputy Billy Kelleher asked the Minister for Health the status of the drug Translarna for the treatment of Duchenne muscular dystrophy, which is currently available to 80% of eligible persons across the EU, including in Northern Ireland, Scotland, England, Wales and the Isle of Man; the details of the engagement between the HSE and the manufacturer to date; and if he will make a statement on the matter. [11194/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Reimbursement

  xml · EN · 7 March 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.